Nyendak, Melissa
Swarbrick, Gwendolyn M.
Duncan, Amanda
Cansler, Meghan
Huff, Ervina Winata
Hokey, David
Evans, Tom
Barker, Lewellys
Blatner, Gretta
Sadoff, Jerald
Douoguih, Macaya
Pau, Maria Grazia
Lewinsohn, Deborah A.
Lewinsohn, David M.
Article History
Received: 29 April 2016
Accepted: 13 October 2016
First Online: 2 November 2016
Competing interests
: Aeras TB Vaccine Foundation has licensed technology (not the subject of this research) from OHSU of which Dr. David Lewinsohn and Dr. Deborah Lewinsohn are inventors. OHSU, Dr. David Lewinsohn, and Dr. Deborah Lewinsohn and Dr. Melissa Nyendak have a financial interest in ViTi, Inc., a company that may have a commercial interest in some research results reported herein. These potential conflicts of interest have been reviewed and managed by OHSU.